default author photo

Alexander Plotnikov

Weizmann Institute of Science - Nancy and Stephen Grand Israel National Center for Personalized Medicine (INCPM)

SCHOLARLY PAPERS

1

DOWNLOADS

26

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

RKI-1447, a ROCK Inhibitor, Targets SRSF2 Mutated Leukemia by Disrupting Cell Mitosis and Nuclear Morphology

Number of pages: 69 Posted: 05 Jul 2023
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology, Weizmann Institute of Science - Department of Molecular and Cellular Biology, Weizmann Institute of Science - Department of Immunology, Weizmann Institute of Science - Department of Immunology, Mount Sinai Health System - Department of Oncological Sciences, Weizmann Institute of Science - Department of Immunology, Weizmann Institute of Science - Nancy and Stephen Grand Israel National Center for Personalized Medicine (INCPM), Weizmann Institute of Science - Nancy and Stephen Grand Israel National Center for Personalized Medicine (INCPM), Weizmann Institute of Science - Nancy and Stephen Grand Israel National Center for Personalized Medicine (INCPM), Weizmann Institute of Science - Department of Molecular and Cellular Biology, University of Toronto - Princess Margaret Cancer Centre, Weizmann Institute of Science - Department of Molecular and Cellular Biology, Mount Sinai Health System - Icahn School of Medicine, Weizmann Institute of Science - Electron Microscopy Unit, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology, Weizmann Institute of Science - Department of Molecular and Cellular Biology, Weizmann Institute of Science - Department of Immunology and Weizmann Institute of Science - Department of Molecular and Cellular Biology
Downloads 26 (1,372,601)

Abstract:

Loading...

SRSF2, Cytoskeleton, ROCK, Nuclear morphology